El propósito del curso es recoger las tendencias y novedades actuales en los mercados de las nuevas sustancias psicoactivas en Europa, discutir las políticas actuales e identificar barreras y problemas para el desarrollo de respuestas efectivas en términos de reducción de daños en Europa. Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.


Venue and dates: EMCDDA Lisbon, 23 – 25 Nov 2015, arrival 22.11

The training is for service providers and peers supporting NPS users in Europe.

Learning Objectives

By the end of the training, participants will be able to:

  • Recall the 7 main drug categories that NPS fall in to

  • Give an overview of relevant NPS substances in Europe

  • Recall current trends and developments in European NPS markets

  • Identify current patterns of use of NPS in Europe

  • Recall current drug patterns and policies in Europe including legal developments and restrictions affecting NPS

  • Identify barriers and problems in developing effective harm reduction responses targeting people who use drugs heavily in Europe (PUDH)

  • Recall best practice examples for responding to NPS users

  • Develop effective harm reduction service responses for NPS users relevant to their client/user group

If you would like to apply for this training, please submit a short written statement outlining:

  • What is your current role?

  • What contact do you have NPS users in your current service?

  • Why you would like to attend the training?

  • What would you like to get out of this training?

Please submit your request to administration@correlation-net.org before 1st September. Places are limited and selection will take place based on regional coverage and informations in your statement. The training is free of charge.Travel and attendance costs will be covered. We inform you before September, the 15th about the acceptance of your application.

Click here for more information.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.